Influence of preparation of BNO 1030 on pro-/antioxidant status of the blood in experimental type 1 diabetes mellitus
Main Article Content
Background. Among the mechanisms that lead to the development and deterioration of the diabetes mellitus type 1 (DM1) and its complications, an important role belongs to the intensification of oxidative stress. In the development of many late complications of DM1, in particular, micro- and macroangiopathies, nephropathy and others, oxidative stress is one of the main pathogenetic mechanisms. Objective. To evaluate the effect of phytopreparation BNO 1030 on pro/antioxidant status of the blood in experimental type 1 diabetes mellitus. Materials and methods. The studies were performed on intact male Wistar rats, in which experimental DM1 was modeled. The production of reactive oxygen species in the blood was measured using 2’,7’-dichlorofluorescein diacetate. The content of living, apoptotic and necrotic leukocytes was determined using annexin V conjugated with GFP (green fluorescent protein) and PI (propidium iodide). Results. Against the background of a decrease in body weight and an increase in the concentration of glucose in the blood of diabetic animals, an enhanced formation of reactive oxygen species was established in comparison with the control group of animals that indicates an intensification of the oxidative stress. Under these conditions, the activity of superoxide dismutase decreased, which indicates a violation of regulation between pro- and antioxidant processes. Conclusions. Administration of BNO 1030 to animals with experimental DM1 resulted in the slight intensification of the production of reactive oxygen species both in the control and in the diabetic group, but its effect increased the viability of immune cells, preventing their death. The use of BNO 1030 resulted in an increase of the activity of superoxide dismutase by 10 % compared to the group of diabetic animals.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Chattopadhyay S, Ramanathan M, Das J, Bhattacharya SK. Animal models in experimental diabetes mellitus. Indian Journal of Experimental Biology. 1997;35(11):1141-5. PMID: 9567740.
Ewing JF, Janero DR. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal Biochem. 1995;232(2):243-248. PMID: 8747482. doi: 10.1006/abio.1995.0014.
Kashiwagi A, Asahina T, Nishio Y. et al. Glycation, oxidative stress, and scavenger activity. Glucose metabolism and radical scavenger dysfunction in endothelial cells. Diabetes 1996;45:84-86. PMID: 8674901.
Muller J, Hoepelman AIM, Rutten GEHM Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus. Clinical Infectious Diseases. 2005;41(3):281-8. PMID: 16007521. doi: 10.1086/431587.
Prentki M, Nolan CJ. Islet β cell failure in type 2 diabetes. J Inv. 2006;116(7):1802-1812. PMID: 16823478. doi: 10.1172/JCI29103.
Poitout V, Robertson RP. Minireview: secondary β-cell failure in type 2 diabetes – a convergence of glucotoxicity and lipotoxicity. Endocrinology 2002;143(2):339-342. PMID: 11796484. doi: 10.1210/endo.143.2.8623.
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44-84. PMID: 16978905. doi: 10.1016/j.biocel.2006.07.001.
Yang H, Jin X, Lam CWK, Yan SK. Oxidative stress and diabetes mellitus. Clin Chem Lab Med. 2011;49(11):1773-82. PMID: 21810068. doi: 10.1515/CCLM.2011.250.
Zheng W, Huang LZ, Zhao L, Wang B, Xu HB, Wang GY, Wang ZL, Zhou H. Superoxide dismutase activity and malondialdehyde level in plasma and morphological evaluation of acute severe hemorrhagic shock in rats. Am J Emerg Med. 2008;26(1):54-58. PMID: 18082781. doi: 10.1016/j.ajem.2007.02.007.
Yasunari K, Maeda K, Nakamura M, Yoshikawa J. Oxidative stress in leukocytes is a possible link between Blood pressure, Blood Glucose, and C-Reacting Protein. Hypertension. 2002;39:777-80. doi: 10.1161/hy0302.104670.
Berger T. Tolerability and efficacy of a herbal combination preparation in children and adolescents with recurrent infections of the upper respiratory tract. MMW Fortschr Med. 2008;150(2):85-90. (In German). PMID: 18712128.
Stavniichuk R, Drel VR, Shevalye H, Maksimchyk Y, Kuchmerovska TM, Nadler JL, Obrosova IG. Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative-nitrosative stress and p38 MAPK activation. Exp Neurol. 2011;230(1):106-13. PMID: 21515260. doi: 10.1016/j.expneurol.2011.04.002.